FDA Inspection
Redmed IncRedmed Inc – FDA Inspection, Dec 12, 2024
Record Details
This FDA Inspection record concerns Redmed Inc, with an inspection on December 12, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a5ed1e17-f0f3-442d-a3ee-a2039cf000df
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1258018
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Redmed Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 24, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 24, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 19, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Redmed Inc
- FDA Inspection 1098290 - 2019-06-24
- FDA Inspection 867835 - 2014-02-24
- FDA Inspection 685683 - 2010-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.